Evidence map›Paper›PMID 32916975›Full record

ArticleMarine drugs2020

Ameliorating Effect of Pentadecapeptide Derived from

Xiaoxia Jiang, Zhexin Ren, Biying Zhao, Shuyao Zhou, Xiaoguo Ying, Yunping Tang

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Nephrotoxicity in cancer treatment: An update.Advances in cancer research · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaoxia JiangZhejiang Provincial Engineering Technology Research Center of Marine Biomedical Products, School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.
Zhexin RenZhejiang Provincial Engineering Technology Research Center of Marine Biomedical Products, School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.
Biying ZhaoZhejiang Provincial Engineering Technology Research Center of Marine Biomedical Products, School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.
Shuyao ZhouZhejiang Provincial Engineering Technology Research Center of Marine Biomedical Products, School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.
Xiaoguo YingZhejiang Provincial Engineering Technology Research Center of Marine Biomedical Products, School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.
Yunping TangZhejiang Provincial Engineering Technology Research Center of Marine Biomedical Products, School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.ORCID 0000-0002-4450-2956
Zhejiang Ocean University · CN

Funding

National Natural Science Foundation of China 41806157
6 · The paper itself

Abstract

Cyclophosphamide (CTX) is a widely used anticancer drug with severe nephrotoxicity. The pentadecapeptide (RVAPEEHPVEGRYLV) from

Indexed as

Amino Acid SequenceAnimalsAnti-Inflammatory AgentsApoptosisApoptosis Regulatory ProteinsBivalviaCyclophosphamideCytokinesDisease Models, AnimalInflammation MediatorsKidneyKidney DiseasesMaleMalondialdehydeMice, Inbred ICRNF-kappa BAnti-Inflammatory AgentsApoptosis Regulatory ProteinsCyclophosphamideCytokinesInflammation MediatorsMalondialdehydeNF-kappa BPeptidesapoptotic pathwayCyclina sinensiskidney nephrotoxicityNF-κB pathwaypentadecapeptide

Identifiers

PMID32916975
PMCPMC7551019
OpenAlexW3084927431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.